PHKA1
Basic information
Region (hg38): X:72578814-72714319
Previous symbols: [ "PHKA" ]
Links
Phenotypes
GenCC
Source:
- glycogen storage disease IXd (Strong), mode of inheritance: XL
- glycogen storage disease IXd (Strong), mode of inheritance: XL
- glycogen storage disease IXd (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glycogen storage disease, type IXd | XL | Pharmacogenomic; Musculoskeletal; Renal | Individuals should avoid circumstances such as vigorous exercise as well as certain medications (eg, succinylcholine, statins) due to risk of rhabdomyolysis | Biochemical; Musculoskeletal; Renal | 2252364; 7874115; 9731190; 12825073; 21634085 |
ClinVar
This is a list of variants' phenotypes submitted to
- Glycogen storage disease IXd (13 variants)
- not provided (3 variants)
- Glycogen phosphorylase kinase deficiency (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHKA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 77 | 86 | ||||
missense | 215 | 225 | ||||
nonsense | 11 | 13 | ||||
start loss | 0 | |||||
frameshift | 7 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 13 | 14 | 2 | 29 | ||
non coding | 20 | 74 | 37 | 131 | ||
Total | 15 | 10 | 238 | 159 | 48 |
Highest pathogenic variant AF is 0.0000269
Variants in PHKA1
This is a list of pathogenic ClinVar variants found in the PHKA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-72578892-T-C | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72578946-A-T | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72579137-C-A | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72579205-T-C | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72579627-T-C | Glycogen storage disease IXd | Benign (Jan 13, 2018) | ||
X-72579699-A-G | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72579727-T-C | Glycogen storage disease IXd | Conflicting classifications of pathogenicity (Dec 01, 2022) | ||
X-72579737-TAC-T | Glycogen phosphorylase kinase deficiency | Uncertain significance (Jun 14, 2016) | ||
X-72579737-T-TAC | Glycogen phosphorylase kinase deficiency | Benign (Jun 14, 2016) | ||
X-72579737-T-TACAC | Glycogen phosphorylase kinase deficiency | Uncertain significance (Jun 14, 2016) | ||
X-72579851-G-A | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72580115-T-C | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72580198-G-A | Glycogen storage disease IXd | Benign (Jan 13, 2018) | ||
X-72580230-G-A | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72580328-T-G | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72580371-CAG-C | Glycogen phosphorylase kinase deficiency | Benign (Jun 14, 2016) | ||
X-72580449-G-A | Glycogen storage disease IXd | Uncertain significance (Jan 12, 2018) | ||
X-72580499-G-A | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72580502-G-T | Glycogen storage disease IXd | Benign (Jan 12, 2018) | ||
X-72580535-A-G | Glycogen storage disease IXd | Uncertain significance (Jan 13, 2018) | ||
X-72580771-T-A | Glycogen storage disease IXd | Benign (Jan 13, 2018) | ||
X-72581005-T-C | Glycogen storage disease IXd | Benign (Jan 13, 2018) | ||
X-72581017-G-A | Glycogen storage disease IXd | Likely benign (Mar 17, 2022) | ||
X-72581043-C-T | Glycogen storage disease IXd | Uncertain significance (Aug 17, 2023) | ||
X-72581044-G-A | Glycogen storage disease IXd | Likely benign (Aug 27, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PHKA1 | protein_coding | protein_coding | ENST00000373542 | 32 | 135504 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.09e-7 | 1.00 | 125714 | 13 | 20 | 125747 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.88 | 363 | 479 | 0.758 | 0.0000368 | 7976 |
Missense in Polyphen | 94 | 151.89 | 0.61887 | 2513 | ||
Synonymous | -0.546 | 177 | 168 | 1.05 | 0.0000123 | 2386 |
Loss of Function | 4.33 | 22 | 57.4 | 0.383 | 0.00000484 | 858 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000189 | 0.000160 |
Ashkenazi Jewish | 0.000134 | 0.0000992 |
East Asian | 0.000361 | 0.000272 |
Finnish | 0.000125 | 0.0000924 |
European (Non-Finnish) | 0.000197 | 0.000141 |
Middle Eastern | 0.000361 | 0.000272 |
South Asian | 0.000318 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin.;
- Disease
- DISEASE: Glycogen storage disease 9D (GSD9D) [MIM:300559]: A metabolic disorder characterized by slowly progressive, predominantly distal muscle weakness and atrophy. Clinical features include exercise intolerance with early fatigability, pain, cramps and occasionally myoglobinuria. {ECO:0000269|PubMed:12825073}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Glucagon signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Glycogen Metabolism;Metabolism of carbohydrates;Metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism
(Consensus)
Recessive Scores
- pRec
- 0.190
Intolerance Scores
- loftool
- 0.0318
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.46
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.759
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.184
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phka1
- Phenotype
- homeostasis/metabolism phenotype; muscle phenotype;
Gene ontology
- Biological process
- glycogen metabolic process;generation of precursor metabolites and energy;protein phosphorylation
- Cellular component
- cytosol;plasma membrane;phosphorylase kinase complex
- Molecular function
- phosphorylase kinase activity;calmodulin binding